SecBot SecBot
Home › SEC Filings

SEC Filing Analysis

10,000+ reports analyzed by SecBot AI · browse by date or by stock
TickerTypeSentimentImpactSummaryDate
CLLS6-Kneutral4/10Cellectis presented expanded preclinical data for .HEAL-101, an in vivo base editing candidate targeting APOC3 for severOct 28, 2026
PAC6-Kneutral2/10Pacific Airport Group (PAC) announced a dividend of Ps. 20.80 per share, payable on November 6, 2026, as approved at theOct 28, 2026
EC6-Kneutral2/10Ecopetrol filed a 6-K announcing the dates for its third quarter 2026 earnings release (November 10, 2026) and conferencOct 28, 2026
MFIC425neutral5/10Ares Capital Corporation (ARCC) filed this 425 communication containing a transcript of its October 27, 2026 earnings caOct 28, 2026
KMB8-Kneutral3/10Kimberly-Clark extended the expiration date of its exchange offers for Kenvue notes from October 27 to November 2, 2026,Oct 28, 2026
HOOD8-K/Aneutral2/10Robinhood filed an amended 8-K/A to revise the presentation of income tax effects on non-GAAP adjustments, with no changOct 28, 2026
EPAC8-Kneutral3/10Enerpac Tool Group Corp. entered into a First Amendment to the Agreement and Plan of Merger for its acquisition of SpeciOct 28, 2026
OTIS8-Kneutral5/10Otis reported Q3 2026 net sales of $3.9 billion (up 6% YoY) and adjusted EPS of $1.05, flat YoY and in line with the $1.Oct 28, 2026
LUV424B5bearish5/10Southwest Airlines is issuing $1.25 billion in senior unsecured notes ($600M 5.750% notes due 2029 and $650M 6.000% noteOct 28, 2026
DMC8-Kbearish5/10Del Monte Corporation reported Q3 2026 GAAP diluted EPS of $0.39, below the $0.46 consensus, and revenue of $1.095B, belOct 28, 2026
VRT8-Kbullish6/10Vertiv reported Q3 2026 net sales of $4,313M (up 61% YoY), diluted EPS of $1.95 (up 91% YoY), and adjusted diluted EPS oOct 28, 2026
SITE8-Kbearish5/10SiteOne Landscape Supply reported Q3 2026 net sales of $1.291B, up 3% YoY, and diluted EPS of $1.46, up from $1.31 a yeaOct 28, 2026
VFC8-Kbullish6/10VF Corp reported Q2 FY2027 results that exceeded its own guidance: adjusted operating income of $364M versus guidance ofOct 28, 2026
TXN424B5neutral4/10Texas Instruments priced $2 billion in senior unsecured notes across four tranches (2028-2036) to partially fund its penOct 28, 2026
TER8-Kbullish6/10Teradyne reported Q3 2026 revenue of $1.306B (up 70% YoY) and non-GAAP EPS of $2.29 (up 169% YoY), both exceeding the hiOct 28, 2026
GNRC8-Kbullish6/10Generac reported record Q3 2026 net sales of $1.29B (+16% YoY), with GAAP EPS of $1.83 and adjusted EPS of $2.54, both aOct 28, 2026
AOS8-Kbullish6/10A. O. Smith announced a definitive agreement to sell an 81% interest in its China business to CPE, an alternative asset Oct 28, 2026
QNRXS-3neutral3/10Quoin Pharmaceuticals filed a universal shelf registration statement on Form S-3 to offer and sell up to $150 million inOct 28, 2026
SNDLSC TO-Cneutral4/10SNDL Inc. filed a pre-commencement communication announcing a potential substantial issuer bid (SIB) to repurchase up toOct 28, 2026
LU6-Kbearish6/10Lufax reported Q3 2026 results with total income down 4.6% YoY to RMB6,180 million and net loss widening 293% to RMB1,49Oct 28, 2026
LVS8-Kneutral3/10Sands China Ltd., the majority-owned subsidiary of Las Vegas Sands Corp., priced $1.0 billion of senior unsecured notes Oct 28, 2026
BFH8-Kbearish5/10Bread Financial Holdings priced an underwritten public offering of 5,000,000 depositary shares (Series C Preferred StockOct 28, 2026
PDS6-Kneutral5/10Precision Drilling reported Q3 2026 results with revenue up 15% YoY to $532M and net earnings of $21M vs a net loss of $Oct 28, 2026
SKYASC TO-I/Aneutral6/10SkyAI amended its issuer tender offer to include all outstanding stapled warrants and increase pre-funded warrant purchaOct 28, 2026
TELPRESS-RELEASEbullish6/10TE Connectivity reported Q4 fiscal 2026 results with record net sales of $5.31B, up 12% YoY, and adjusted EPS of $3.14, Oct 28, 2026
FCFSPRESS-RELEASEneutral3/10FirstCash increased its share repurchase authorization by $200M to $350M, with $222M remaining. The company has already Oct 28, 2026
RAPPPRESS-RELEASEbearish6/10Rapport Therapeutics priced a combined capital raise of approximately $380 million, comprising a $200 million common stoOct 28, 2026
GNRCPRESS-RELEASEbullish6/10Generac reported Q3 2026 adjusted EPS of $2.54, beating the $2.43 consensus by 4.5%, and record revenue of $1.29B, slighOct 28, 2026
RDWRPRESS-RELEASEbullish6/10Radware reported Q3 2026 revenue of $84.4M (+12% YoY), beating the $83.0M consensus. Non-GAAP EPS of $0.32 beat the $0.2Oct 28, 2026
CSTMPRESS-RELEASEbullish6/10Constellium reported Q3 2026 revenue of $2.6B (up 22% YoY) and GAAP diluted EPS of $0.84, beating the $0.75 consensus. AOct 28, 2026
« Previous Page 35 of 334 Next »